FDA approves women's libido drug

The FDA has approved Vyleesi, a drug for premenopausal women with hypoactive sexual desire disorder.

The drug is an under-the-skin injection that women would use about 45 minutes before anticipated sexual activity. It is intended to increase desire in women who experience "low sexual desire that causes marked distress or interpersonal difficulty."

The approval of Vyleesi is controversial, according to STAT. Critics claim that prescribing a drug to increase sexual desire reduces the complexity of human sexuality to a biological issue. 

More articles on pharmacy:
Lupin recalls 18,408 bottles of antibiotic in US
Bluebird Bio prices gene therapy at $1.8M
10 hospitals seeking pharmacy leaders

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars